About
Angioslide provides physicians with cost-effective products for emboli management during vascular interventions. The company is the developer of PROTEUS, an FDA-cleared device that enables physicians to capture and remove embolic particles dislodged at the lesion site in peripheral arteries. PROTEUS functions like an angioplasty balloon, with the same physical and behavioral characteristics, including inflation time, deflation time, pushability, and crossing profile. In addition, the PROTEUS embolic capture feature involves a single-use suction mechanism that works through inward folding of the balloon, which creates negative pressure within the capture cavity for debris capture and removal. The reduced pressure in the capture cavity causes some of the particles released during the procedure to flow into the cavity for containment and removal. PROTEUS has received CE and FDA clearances for lower limb use.